Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

20. August 2021 - 0:00 (CEST)

Epigenomics AG: Reduction of principal amount of planned mandatory convertible bond to up to EUR 16.5 million and of conversion price to EUR 1.10 per share

Read more

17. August 2021 - 0:00 (CEST)

Epigenomics AG: Execution of a Biobank Sale Agreement and Update of Guidance

Read more

11. June 2021 - 0:00 (CEST)

Epigenomics AG plans to issue mandatory convertible bond in the amount of up to EUR 18.15 million

Read more

Press releases

11. May 2022

Epigenomics AG Reports Financial Results for the First Quarter of 2022

Read more

24. March 2022

Epigenomics AG Reports Financial Results for Fiscal Year 2021

Read more

24. January 2022

Supervisory Board of Epigenomics AG Retains Greg Hamilton as Chief Executive Officer Through Development of Epi proColon ‘Next-Gen’ Colorectal Cancer Screening Test

Read more